Study | Reason for exclusion |
---|---|
Baroody 2001 | ALLOCATION Randomised controlled trial PARTICIPANTS Patients with perennial allergic rhinitis (not atrophic rhinitis) |
Borgstein 1993 | ALLOCATION Not a true RCT, compared groups were not totally similar and the study had insufficient information available |
Fang 1998 | ALLOCATION Clinical controlled trial (not a RCT) |
Jaswal 2008 | ALLOCATION Randomised controlled trial PARTICIPANTS 30 patients with primary atrophic rhinitis INTERVENTIONS Oral rifampicin plus nasal wash versus nasal submucosal placentrex injection plus nasal wash and a control group (nasal wash) OUTCOMES Excluded on the basis of insufficient duration of follow‐up. Oral rifampicin showed most promising results regarding objective, subjective and histopathological improvement with maximum disease‐free interval on regular follow‐up as compared to submucosal placentrex injections, while both performed better than control group. |
Johnsen 2001 | ALLOCATION
Randomised cross‐over study PARTICIPANTS Non‐specific nasal dryness (not atrophic rhinitis) |
Kehrl 1998 | ALLOCATION Randomised, double‐blind study PARTICIPANTS Rhinitis sicca anterior (not atrophic rhinitis) |
Klemi 1980 | ALLOCATION: Non‐randomised double‐blind study (patients with allergic rhinitis) |
Klossek 2001 | ALLOCATION Not randomised |
Laliberte 2000 | ALLOCATION Not randomised |
Mehrotra 2005 | ALLOCATION Not randomised |
Nemeth 2002 | ALLOCATION Not randomised |
Nielsen 1995 | ALLOCATION: Case series revealing clinical response in 10 patients with ozaena |
Schwartz 2007 | ALLOCATION Not randomised |
Shehata 1996 | ALLOCATION A review article with no treatment arm |
Stoll 1958 | ALLOCATION Possibly a case series of a single agent (inplacen) response in a series of patients. The study is very old, in the German language and incomplete information information is available to conclude exclusion |
Stoor 1999 | ALLOCATION Not randomised |
RCT: randomised controlled trial